Literature DB >> 20351292

Contribution of SHP-1 protein tyrosine phosphatase to osmotic regulation of the transcription factor TonEBP/OREBP.

Xiaoming Zhou1, Morgan Gallazzini, Maurice B Burg, Joan D Ferraris.   

Abstract

Hypertonicity activates the transcription factor TonEBP/OREBP, resulting in increased expression of osmoprotective genes, including those responsible for accumulation of organic osmolytes and heat-shock proteins. Phosphorylation of TonEBP/OREBP contributes to its activation. Several of the kinases that are involved were previously identified, but the phosphatases were not. In the present studies we screened a genomewide human phosphatase siRNA library in human embryonic kidney (HEK)293 cells for effects on TonEBP/OREBP transcriptional activity. We found that siRNAs against 57 phosphatases significantly alter TonEBP/OREBP transcriptional activity during normotonicity (290 mosmol/kg) or hypertonicity (500 mosmol/kg, NaCl added) or both. Most siRNAs increase TonEBP/OREBP activity, implying that the targeted phosphatases normally reduce that activity. We further studied in detail SHP-1, whose knockdown by its specific siRNA increases TonEBP/OREBP transcriptional activity at 500 mosmol/kg. We confirmed that SHP-1 is inhibitory by overexpressing it, which reduces TonEBP/OREBP transcriptional activity at 500 mosmol/kg. SHP-1 dephosphorylates TonEBP/OREBP at a known regulatory site, Y143, both in vivo and in vitro. It inhibits TonEBP/OREBP by both reducing TonEBP/OREBP nuclear localization, which is Y143 dependent, and by lowering high NaCl-induced TonEBP/OREBP transactivating activity. SHP-1 coimmunoprecipitates with TonEBP/OREBP and vice versa, suggesting that they are physically associated in the cell. High NaCl inhibits the effect of SHP-1 on TonEBP/OREBP by increasing phosphorylation of SHP-1 on Ser591, which reduces its phosphatase activity and localization to the nucleus. Thus, TonEBP/OREBP is extensively regulated by phosphatases, including SHP-1, whose inhibition by high NaCl increases phosphorylation of TonEBP/OREBP at Y143, contributing to the nuclear localization and activation of TonEBP/OREBP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351292      PMCID: PMC2872470          DOI: 10.1073/pnas.1002795107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.

Authors:  Alastair W Poole; Matthew L Jones
Journal:  Cell Signal       Date:  2005-11       Impact factor: 4.315

2.  A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis.

Authors:  Roddy S O'Connor; Stephen T Mills; Kristen A Jones; Steffan N Ho; Grace K Pavlath
Journal:  J Cell Sci       Date:  2006-12-12       Impact factor: 5.285

3.  MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP.

Authors:  Tsung-Ting Tsai; Asha Guttapalli; Amit Agrawal; Todd J Albert; Irving M Shapiro; Makarand V Risbud
Journal:  J Bone Miner Res       Date:  2007-07       Impact factor: 6.741

4.  Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production.

Authors:  Geneviève Forget; David J Gregory; Lorie A Whitcombe; Martin Olivier
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

5.  Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression.

Authors:  Todd Lamitina; Chunyi George Huang; Kevin Strange
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

6.  Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31.

Authors:  N J Pumphrey; V Taylor; S Freeman; M R Douglas; P F Bradfield; S P Young; J M Lord; M J Wakelam; I N Bird; M Salmon; C D Buckley
Journal:  FEBS Lett       Date:  1999-04-30       Impact factor: 4.124

7.  Regulation of nucleocytoplasmic trafficking of transcription factor OREBP/TonEBP/NFAT5.

Authors:  Edith H Y Tong; Jin-Jun Guo; Ai-Long Huang; Han Liu; Chang-Deng Hu; Stephen S M Chung; Ben C B Ko
Journal:  J Biol Chem       Date:  2006-06-16       Impact factor: 5.157

8.  Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity.

Authors:  H Miyakawa; S K Woo; S C Dahl; J S Handler; H M Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

9.  Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity.

Authors:  Yin Liu; Michael J Kruhlak; Jian-Jiang Hao; Stephen Shaw
Journal:  J Leukoc Biol       Date:  2007-06-15       Impact factor: 4.962

10.  NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site.

Authors:  Shahin Ranjbar; Alla V Tsytsykova; Sang-Kyung Lee; Ricardo Rajsbaum; James V Falvo; Judy Lieberman; Premlata Shankar; Anne E Goldfeld
Journal:  PLoS Pathog       Date:  2006-12       Impact factor: 6.823

View more
  19 in total

1.  PKC-α contributes to high NaCl-induced activation of NFAT5 (TonEBP/OREBP) through MAPK ERK1/2.

Authors:  Hong Wang; Joan D Ferraris; Janet D Klein; Jeff M Sands; Maurice B Burg; Xiaoming Zhou
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-12

Review 2.  How do kinases contribute to tonicity-dependent regulation of the transcription factor NFAT5?

Authors:  Xiaoming Zhou
Journal:  World J Nephrol       Date:  2016-01-06

3.  Peptide affinity analysis of proteins that bind to an unstructured NH2-terminal region of the osmoprotective transcription factor NFAT5.

Authors:  Jenna F DuMond; Kevin Ramkissoon; Xue Zhang; Yuichiro Izumi; Xujing Wang; Koji Eguchi; Shouguo Gao; Masashi Mukoyama; Maurice B Burg; Joan D Ferraris
Journal:  Physiol Genomics       Date:  2016-01-12       Impact factor: 3.107

4.  EAE-induced upregulation of mitochondrial MnSOD is associated with increases of mitochondrial SGK1 and Tom20 protein in the mouse kidney cortex.

Authors:  Sharanpreet Hira; Balamuguran Packialakshmi; Xiaoming Zhou
Journal:  J Physiol Sci       Date:  2019-06-08       Impact factor: 2.781

5.  Peptide affinity analysis of proteins that bind to an unstructured region containing the transactivating domain of the osmoprotective transcription factor NFAT5.

Authors:  Jenna F Dumond; Xue Zhang; Yuichiro Izumi; Kevin Ramkissoon; Guanghui Wang; Marjan Gucek; Xujing Wang; Maurice B Burg; Joan D Ferraris
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

6.  Mutations that reduce its specific DNA binding inhibit high NaCl-induced nuclear localization of the osmoprotective transcription factor NFAT5.

Authors:  Yuichiro Izumi; Jinxi Li; Courtney Villers; Kosuke Hashimoto; Maurice B Burg; Joan D Ferraris
Journal:  Am J Physiol Cell Physiol       Date:  2012-09-19       Impact factor: 4.249

7.  Rac1/osmosensing scaffold for MEKK3 contributes via phospholipase C-gamma1 to activation of the osmoprotective transcription factor NFAT5.

Authors:  Xiaoming Zhou; Yuichiro Izumi; Maurice B Burg; Joan D Ferraris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-28       Impact factor: 11.205

8.  Inhibitory phosphorylation of GSK-3β by AKT, PKA, and PI3K contributes to high NaCl-induced activation of the transcription factor NFAT5 (TonEBP/OREBP).

Authors:  Xiaoming Zhou; Hong Wang; Maurice B Burg; Joan D Ferraris
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-16

9.  Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle.

Authors:  Erick O Hernández-Ochoa; Patrick Robison; Minerva Contreras; Tiansheng Shen; Zhiyong Zhao; Martin F Schneider
Journal:  Exp Biol Med (Maywood)       Date:  2012-09-10

10.  High NaCl-induced inhibition of PTG contributes to activation of NFAT5 through attenuation of the negative effect of SHP-1.

Authors:  Xiaoming Zhou; Hong Wang; Maurice B Burg; Joan D Ferraris
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.